195 related articles for article (PubMed ID: 21922339)
1. Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus and good outcome with rituximab treatment.
Sanz PG; García Méndez CV; Cueto AL; Silva VB; Walther JC; Diez RA; Martins S; Giannaula RJ
Rheumatol Int; 2012 Dec; 32(12):4061-3. PubMed ID: 21922339
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide.
Jasmin R; Sockalingam S; Shahrizaila N; Cheah TE; Zain AA; Goh KJ
Lupus; 2012 Sep; 21(10):1119-23. PubMed ID: 22433918
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus without systemic activity.
Calixto OJ; Poveda S; Meneses-Toro MA; Vera-Parra EC; Romero-Sánchez C; Guzman Molano LF; Bello-Gualtero JM
Lupus; 2023 Aug; 32(9):1123-1125. PubMed ID: 37369195
[TBL] [Abstract][Full Text] [Related]
4. The initial presentation of systemic lupus erythematosis with aplastic anemia successfully treated with rituximab.
Alishiri GH; Saburi A; Bayat N; Saadat AR; Saburi E
Clin Rheumatol; 2012 Feb; 31(2):381-4. PubMed ID: 22015937
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review.
Bright RJ; Wilkinson J; Coventry BJ
BMC Neurol; 2014 Feb; 14():26. PubMed ID: 24507546
[TBL] [Abstract][Full Text] [Related]
6. Current and novel therapeutics in the treatment of systemic lupus erythematosus.
Yildirim-Toruner C; Diamond B
J Allergy Clin Immunol; 2011 Feb; 127(2):303-12; quiz 313-4. PubMed ID: 21281862
[TBL] [Abstract][Full Text] [Related]
7. A case of Evans syndrome combined with systemic lupus erythematosus successfully treated with rituximab.
Kittaka K; Dobashi H; Baba N; Iseki K; Kameda T; Susaki K; Kitanaka A; Kubota Y; Ishida T
Scand J Rheumatol; 2008; 37(5):390-3. PubMed ID: 18609263
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
Sederholm BH
Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
[TBL] [Abstract][Full Text] [Related]
9. Colitis associated with active systemic lupus erythematosus successfully treated with rituximab.
Tayal V; Chiu YH; George E; Mane S
J Clin Rheumatol; 2011 Mar; 17(2):79-82. PubMed ID: 21325960
[TBL] [Abstract][Full Text] [Related]
10. Chronic inflammatory demyelinating polyradiculoneuropathy associated with systemic lupus erythematosus.
Julio PR; Cortês MMM; Costallat LTL; Gaino JZ; França MC; Appenzeller S
Semin Arthritis Rheum; 2021 Feb; 51(1):158-165. PubMed ID: 33383292
[TBL] [Abstract][Full Text] [Related]
11. Remission of chronic inflammatory demyelinating polyneuropathy after alemtuzumab (Campath 1H).
Hirst C; Raasch S; Llewelyn G; Robertson N
J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):800-2. PubMed ID: 16705208
[No Abstract] [Full Text] [Related]
12. Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus.
Münch C; Anagnostou P; Meyer R; Haas J
J Neurol Sci; 2007 May; 256(1-2):100-2. PubMed ID: 17382963
[TBL] [Abstract][Full Text] [Related]
13. Rituximab therapy in chronic inflammatory demyelinating polyradiculoneuropathy with anti-SGPG IgM antibody.
Gono T; Matsuda M; Shimojima Y; Ishii W; Yamamoto K; Morita H; Hashimoto T; Susuki K; Yuki N; Ikeda S
J Clin Neurosci; 2006 Jul; 13(6):683-7. PubMed ID: 16814550
[TBL] [Abstract][Full Text] [Related]
14. Pediatric systemic lupus erythematosus in Thammasat University Hospital.
Pusongchai T; Jungthirapanich J; Khositseth S
J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S283-93. PubMed ID: 21294427
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.
Cocito D; Grimaldi S; Paolasso I; Falcone Y; Antonini G; Benedetti L; Briani C; Fazio R; Jann S; Matà S; Sabatelli M; Nobile-Orazio E;
Eur J Neurol; 2011 Dec; 18(12):1417-21. PubMed ID: 21819489
[TBL] [Abstract][Full Text] [Related]
16. Oral mucosal involvement in bullous lupus.
Anyanwu CO; Ang CC; Werth VP
Arthritis Rheum; 2013 Oct; 65(10):2622. PubMed ID: 23780804
[No Abstract] [Full Text] [Related]
17. Lewis-Sumner syndrome in a patient with rheumatoid arthritis: Link between rheumatoid arthritis and demyelinating polyradiculoneuropathies.
Kedra J; Foltz V; Viala K; Tan S; Fautrel B
Joint Bone Spine; 2017 Jul; 84(4):485-487. PubMed ID: 28363822
[TBL] [Abstract][Full Text] [Related]
18. [Rituximab as treatment for thrombocytopenic thrombotic purpura associated with systemic lupus erythematosus].
López Carmona D; Pérez de Pedro I; de Ramón E; Camps García MT
Med Clin (Barc); 2007 Dec; 129(20):797-8. PubMed ID: 18093482
[No Abstract] [Full Text] [Related]
19. Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis.
Sadnicka A; Reilly MM; Mummery C; Brandner S; Hirsch N; Lunn MP
J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):230-2. PubMed ID: 20462915
[TBL] [Abstract][Full Text] [Related]
20. Immunologic reconstitution after rituximab in systemic lupus erythematosus: why should we care?
Anolik J
J Rheumatol; 2011 Apr; 38(4):587-9. PubMed ID: 21459953
[No Abstract] [Full Text] [Related]
[Next] [New Search]
